ClinicalTrials.Veeva
Menu

Find clinical trials for Eczema in Miami, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Atopic Dermatitis
Dermatitis
Pruritus
Food Hypersensitivity
Hidradenitis
Hidradenitis Suppurativa
Hypersensitivity

Eczema trials near Miami, FL, USA:

A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

This research study is being conducted to find out if the test medicine, abrocitinib, improves eczema and is safe for children 6 to \<12 yea...

Enrolling
Eczema
Drug: Abrocitinib
Other: Placebo

Phase 3

Pfizer
Pfizer

Miami, Florida, United States and 13 other locations

This study will assess the safety and tolerability of ARQ-151 cream 0.05% applied once a day for 4 weeks in infants with atopic dermatitis (eczema...

Enrolling
Atopic Dermatitis (Eczema)
Drug: ARQ-151 cream 0.05%

Phase 2

Arcutis Biotherapeutics
Arcutis Biotherapeutics

Coral Gables, Florida, United States and 12 other locations

The goal of this clinical trial is to assess the safety, tolerability, and pharmacokinetics of ATTO-1310 in healthy adults, patients with atopic derm...

Enrolling
Atopic Eczema
Chronic Pruritus
Drug: ATTO-1310 Placebo
Drug: ATTO-1310

Phase 1

Attovia Therapeutics Inc

Coral Gables, Florida, United States and 13 other locations

the treatment of adults with moderate to severe Atopic Dermatitis (Eczema). OpSCF will be compared to a placebo.OpSCF or placebo will be adm...

Active, not recruiting
Atopic Dermatitis
Biological: Placebo
Biological: OpSCF

Phase 2

Opsidio

Miami, Florida, United States of America and 21 other locations

This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB75...

Enrolling
Atopic Dermatitis (AD)
Biological: BFB759
Drug: Placebo

Phase 2

Bluefin Biomedicine, Inc.

North Miami Beach, Florida, United States of America and 6 other locations

This study will evaluate the efficacy and safety of different doses of EVO756 in adults with moderate to severe atopic dermatitis.

Enrolling
Atoptic Dermatitis
Drug: EVO756
Drug: Placebo control

Phase 2

Evommune

Coral Gables, Florida, United States of America and 10 other locations

The purpose of this study is to evaluate the safety and tolerability of XmAb27564 following multiple doses among participants with plaque psoriasis a...

Active, not recruiting
Atopic Dermatitis
Psoriasis
Biological: XmAb27564
Biological: Placebo

Phase 1

Xencor
Xencor

Coral Gables, Florida, United States of America and 8 other locations

This trial is designed to evaluate multiple compounds in participants with moderate to severe atopic dermatitis (AD).

Enrolling
Atopic Dermatitis
Drug: Placebo
Drug: GHZ339

Phase 2

Novartis
Novartis

Miami, Florida, United States and 16 other locations

This is a phase IIa, randomized, double-blind, placebo-controlled, multi-center proof-of-concept (POC) study in subjects with moderate to severe Atop...

Active, not recruiting
Atopic Dermatitis
Drug: Placebo
Drug: ADX-914

Phase 2

Q32 Bio

Miami, Florida, United States and 26 other locations

This study evaluates ATI-045 versus placebo in patients with Moderate-to-Severe Atopic Dermatitis.

Enrolling
Eczema
Atopic Dermatitis
Drug: ATI-045
Drug: Placebo

Phase 2

Aclaris Therapeutics
Aclaris Therapeutics

Coral Gables, Florida, United States and 22 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems